← Back to Clinical Trials
Recruiting NCT06101056

NCT06101056 Code of Respect (X-CoRe): Trial of a Multi-level Sexual Assault and Sexual Harassment Prevention Intervention for Active Duty Airmen

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06101056
Status Recruiting
Phase —
Sponsor The University of Texas Health Science Center, Houston
Condition Sexual Assault
Study Type INTERVENTIONAL
Enrollment 1,200 participants
Start Date 2024-12-17
Primary Completion 2027-05-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Junior Enlisted ComponentLeadership ComponentSocial Marketing Campaign

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,200 participants in total. It began in 2024-12-17 with a primary completion date of 2027-05-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to examine the efficacy of Code of Respect (X-CoRe) multi-level sexual assault (SA) and harassment (SH) prevention program in improving psychosocial determinants (e.g., knowledge, skills, self-efficacy, attitudes) related to respectful/disrespectful relationships, to examine the efficacy of X-CoRe in reducing SA and sexual harassment SH victimization and to examine the efficacy of X-CoRe increasing bystander behavior and improving unit cohesion and mission readiness by decreasing secondary risk and harmful behaviors (e.g., alcohol misuse, intimate partner violence, suicide ideation). The study will be conducted at at Joint Base McGuire Dix-Lakehurst (JBMDL) located in Burlington County, New Jersey, and participants will be cluster-randomized at the level of the squadron to one of two conditions: the X-CoRe program or a control condition.

Eligibility Criteria

Inclusion Criteria: * Active Duty, stationed at JBMDL * assigned to one of the 26 Air Force squadrons within the three Air Force Wings at JBMDL (87 Air Base Wing (ABW), 305 Air Mobility Wing (ABM), and 621 Contingency Response Wing (CRW)) * English speaking * access to an electronic device with internet capabilities Exclusion Criteria: * being in service branches other than Air Force (e.g., Army or Navy) * Airmen not ranked E1-E4 at JBMDL

Contact & Investigator

Central Contact

Belinda Hernandez, PhD, MPH

✉ Belinda.Hernandez@uth.tmc.edu

📞 (210) 276-9021

Principal Investigator

Belinda Hernandez, PhD, MPH

PRINCIPAL INVESTIGATOR

The University of Texas Health Science Center, Houston

Frequently Asked Questions

Who can join the NCT06101056 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Sexual Assault. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06101056 currently recruiting?

Yes, NCT06101056 is actively recruiting participants. Contact the research team at Belinda.Hernandez@uth.tmc.edu for enrollment information.

Where is the NCT06101056 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT06101056 clinical trial?

NCT06101056 is sponsored by The University of Texas Health Science Center, Houston. The principal investigator is Belinda Hernandez, PhD, MPH at The University of Texas Health Science Center, Houston. The trial plans to enroll 1,200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology